HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Kaj-Erik Klaaborg Carl-Johan Jakobsen Permission Requests Google Scholar Articles by Klaaborg, K.-E. Articles by Thuesen, L. PubMed Articles by Klaaborg, K.-E. Articles by Thuesen, L. Related Collections Valve disease

---

Case Reports

Transapical Transcatheter Treatment of a Stenosed Aortic Valve Bioprosthesis Using the Edwards SAPIEN Transcatheter Heart Valve

^a Department of Thoracic and Cardiovascular Surgery, Aarhus University Hospital, Skejby, Denmark
^b Department of Cardiology, Aarhus University Hospital, Skejby, Denmark
^c Department of Anesthesiology, Aarhus University Hospital, Skejby, Denmark

Accepted for publication November 10, 2008.

^_* Address correspondence to Dr Thuesen, Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus N, 8200, Denmark (Email: leif.thuesen{at}ki.au.dk).

Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Group, Vancouver, British Columbia, Canada) in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve (Edwards Lifesciences, Irvine, CA).